Organ Protection With Sevoflurane Postconditioning After Cardiac Surgery With Cardiopulmonary Bypass
1 other identifier
interventional
120
1 country
1
Brief Summary
Organ protection, volatile anesthetics, postconditioning. Sedation of patients on ICU after cardiac surgery with cardiopulmonary bypass with either propofol or sevoflurane. Evaluation of organ function and inflammatory mediators in the blood.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2007
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2007
CompletedFirst Submitted
Initial submission to the registry
June 17, 2009
CompletedFirst Posted
Study publicly available on registry
June 18, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2009
CompletedOctober 12, 2011
October 1, 2011
2.1 years
June 17, 2009
October 11, 2011
Conditions
Outcome Measures
Primary Outcomes (1)
Myocardial injury markers (myoglobin, creatine kinase, myocard specific creatine kinase, and troponin T)
Start and end of ICU stay
Secondary Outcomes (1)
Oxygenation index, postoperative pulmonary complications, ICU stay (days), length of hospitalisation
Start with surgery until end of hospitalisation
Study Arms (2)
Sevoflurane
EXPERIMENTALPropofol
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- CABG and/or heart valve surgery with CPB
- Ejection fraction (EF) = 30%
- Canadian Cardiovascular Society (CCS) classification = 3
- Ages 18 to 90 years old
You may not qualify if:
- Pulmonary disease: forced expiratory volume in one second (FEV1) \< 80%; FEV1/forced vital capacity (FVC) \< 70%
- Renal disease and/ or creatinine-clearance \< 60 ml/min
- Previous cardiac surgery
- Emergency procedures
- Postoperative intra aortic balloon pump (IABP) requirement
- Myocardial infarction \< 7d
- Steroid treatment
- Insulin-dependent diabetes
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Unknown Facility
Zurich, Switzerland
Related Publications (1)
Steurer MP, Steurer MA, Baulig W, Piegeler T, Schlapfer M, Spahn DR, Falk V, Dreessen P, Theusinger OM, Schmid ER, Schwartz D, Neff TA, Beck-Schimmer B. Late pharmacologic conditioning with volatile anesthetics after cardiac surgery. Crit Care. 2012 Oct 14;16(5):R191. doi: 10.1186/cc11676.
PMID: 23062276DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
01 Studienregister MasterAdmins
UniversitaetsSpital Zuerich
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 17, 2009
First Posted
June 18, 2009
Study Start
October 1, 2007
Primary Completion
November 1, 2009
Study Completion
December 1, 2009
Last Updated
October 12, 2011
Record last verified: 2011-10